Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT.

Am J Psychiatry. 2007 Oct;164(10):1593-602.

PMID:
17898352
2.

D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning.

Duffy S, Labrie V, Roder JC.

Neuropsychopharmacology. 2008 Apr;33(5):1004-18. Epub 2007 Jul 11.

3.

Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

Davis M, Ressler K, Rothbaum BO, Richardson R.

Biol Psychiatry. 2006 Aug 15;60(4):369-75. Review.

PMID:
16919524
4.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.

Arch Gen Psychiatry. 2006 Mar;63(3):298-304.

PMID:
16520435
5.

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR.

Schizophr Bull. 2005 Jan;31(1):5-19. Epub 2005 Feb 16.

PMID:
15888422
6.

Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats.

Parnas AS, Weber M, Richardson R.

Neurobiol Learn Mem. 2005 May;83(3):224-31.

PMID:
15820858
7.

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.

Millan MJ.

Psychopharmacology (Berl). 2005 Apr;179(1):30-53. Epub 2005 Mar 10. Review.

PMID:
15761697
8.

A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia.

Manoach DS, Cain MS, Vangel MG, Khurana A, Goff DC, Stickgold R.

Biol Psychiatry. 2004 Dec 15;56(12):951-6.

PMID:
15601605
9.

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis.

Tuominen HJ, Tiihonen J, Wahlbeck K.

Schizophr Res. 2005 Jan 1;72(2-3):225-34. Review.

PMID:
15560967
10.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M.

Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.

PMID:
15520361
11.

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.

Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D.

Psychopharmacology (Berl). 2005 Apr;179(1):144-50. Epub 2004 Oct 21.

PMID:
15502972
12.

Effects of D-cycloserine on negative symptoms in schizophrenia.

Duncan EJ, Szilagyi S, Schwartz MP, Bugarski-Kirola D, Kunzova A, Negi S, Stephanides M, Efferen TR, Angrist B, Peselow E, Corwin J, Gonzenbach S, Rotrosen JP.

Schizophr Res. 2004 Dec 1;71(2-3):239-48. Review.

PMID:
15474895
13.

An autoradiographic study of the distribution of tritium-labeled cycloserine in mice.

HANNGREN H, HANSSON E, ULLBERG S.

Antibiot Chemother (Northfield). 1962 Jan;12:46-54. No abstract available.

PMID:
13904388
14.

Glycine binding primes NMDA receptor internalization.

Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW.

Nature. 2003 Mar 20;422(6929):302-7.

PMID:
12646920
15.

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

Evins AE, Amico E, Posever TA, Toker R, Goff DC.

Schizophr Res. 2002 Jul 1;56(1-2):19-23.

PMID:
12084415
16.

Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine.

Goff DC, Hennen J, Lyoo IK, Tsai G, Wald LL, Evins AE, Yurgelun-Todd DA, Renshaw PF.

Biol Psychiatry. 2002 Mar 15;51(6):493-7.

PMID:
11922885
17.

Impaired visual memory in rats reared in isolation is reversed by D-cycloserine in the adult rat.

Strømme Johannesen T, Myhrer T.

Eur J Pharmacol. 2002 Feb 15;437(1-2):73-7.

PMID:
11864642
18.

Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats.

Andersen JM, Lindberg V, Myhrer T.

Behav Brain Res. 2002 Feb 1;129(1-2):211-6.

PMID:
11809513
19.
20.

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

Goff DC, Coyle JT.

Am J Psychiatry. 2001 Sep;158(9):1367-77. Review.

PMID:
11532718

Supplemental Content

Support Center